Anlotinib alone or in combination with temozolomide in recurrent high-grade glioma: A retrospective study.

被引：0
|
作者：
Yang, Qun-ying
Guo, Cheng-Cheng
He, Zhenqiang
Lin, Fuhua
Zhang, Ji
Guo, Xiaoyu
Chen, Yinsheng
Jiang, Xiaobing
Ke, Chao
Chen, Zhongping
Mou, Yonggao
机构：
[1] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Neurosurg Neuro Oncol, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ Canc Ctr, Canc Ctr, Dept Neurosurg Neurooncol, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e14019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14019
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study
    Abete-Fornara, Giorgia
    Socaciu, Petra Bintintan
    Fanizzi, Claudia
    Fiore, Giorgio
    Locatelli, Marco
    Caroli, Manuela
    JOURNAL OF NEURO-ONCOLOGY, 2023, 165 (03) : 561 - 568
  • [32] Temozolomide and radiotherapy in high-grade malignant glioma: Update of an observational study
    Ratti, R.
    Coccorullo, Z.
    Orsatti, M.
    Guarneri, D.
    Addamo, G.
    Colloca, G.
    Venturino, A.
    Boccardo, M.
    Campora, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 158 - 158
  • [33] Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study
    Giorgia Abete-Fornara
    Petra Bintintan Socaciu
    Claudia Fanizzi
    Giorgio Fiore
    Marco Locatelli
    Manuela Caroli
    Journal of Neuro-Oncology, 2023, 165 : 561 - 568
  • [34] Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
    Abacioglu, Ufuk
    Caglar, Hale B.
    Yumuk, Perran F.
    Akgun, Zuleyha
    Atasoy, Beste M.
    Sengoz, Meric
    JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 585 - 593
  • [35] Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
    Ufuk Abacioglu
    Hale B. Caglar
    Perran F. Yumuk
    Zuleyha Akgun
    Beste M. Atasoy
    Meric Sengoz
    Journal of Neuro-Oncology, 2011, 103 : 585 - 593
  • [36] BCNU as second line therapy for recurrent high-grade glioma previously treated with temozolomide
    Rosenthal, MA
    Ashley, DL
    Cher, L
    JOURNAL OF CLINICAL NEUROSCIENCE, 2004, 11 (04) : 374 - 375
  • [37] The efficacy and safety of CyberKnife combined with bevacizumab and temozolomide in the treatment of recurrent high-grade glioma
    Jingbo, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S402 - S402
  • [38] Salvage chemotherapy with temozolomide and CPT-11 for recurrent or progressive high-grade glioma
    Terasaki, Mizuhiko
    Fukushima, Shintaro
    Shigemori, Minoru
    NEURO-ONCOLOGY, 2007, 9 (04) : 526 - 526
  • [39] Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    Bower, M
    Newlands, ES
    Bleehen, NM
    Brada, M
    Begent, RJH
    Calvert, H
    Colquhoun, I
    Lewis, P
    Brampton, MH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) : 484 - 488
  • [40] Temozolomide Rechallenge in Patients With Recurrent High-Grade Glioma Treated With Re-Irradiation
    Basree, M. M.
    Ali, A.
    Garg, S.
    Glass, J.
    Kim, L.
    Farrell, C.
    Evans, J.
    Judy, K.
    Andrews, D. W.
    Shi, W.
    Werner-Wasik, M.
    Palmer, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E587 - E588
12345